11th Annual Interdisciplinary Prostate Cancer Congress and other Genitourinary Malignancies

11th Annual Interdisciplinary Prostate Cancer Congress and other Genitourinary Malignancies is organized by Physicians Education Resource, LLC (PER) and will be held on March 24, 2018 at Crowne Plaza Times Square Manhattan, New York City, New York, United States of America.

The target audience for this medical event is medical, surgical, and radiation oncologists involved in the treatment of patients with genitourinary (GU) malignancies. Urologists, fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, nuclear medicine physicians, and other healthcare professionals interested in the treatment of GU malignancies may also participate.

Course Overview :
This course will focus on key clinical topics in the management of genitourinary malignancies, including prognostic/predictive markers in care, proactive methods to mitigate predictable treatment-related side effects, optimal use of chemotherapeutic strategies, androgen-deprivation therapies, targeted therapies, radiopharmaceuticals, and immunotherapies, as well as explore emerging data on various combinations and sequences of treatment strategies currently undergoing clinical trial evaluation. The Congress continues to evolve and expand its coverage of some of the fastest moving areas in the management of genitourinary malignancies. To that end, there will be an expanded focus on bladder cancer and renal cell carcinoma, given recent practice-changing developments that continue to alter the therapeutic landscape in these fields of care. Key questions concerning the application of landmark clinical trial data on emerging targeted and immunotherapeutic options, as well as the application of emerging biomarkers for these tumors, will be answered during expanded sessions on these topics.

Learning Objectives :
• Describe methods to stratify risk and tumor information that can provide the rationale for clinical decision making in the management of GU malignancies.
• Summarize recommendations that shape current strategies to care for patients with GU malignancies.
• Develop multidisciplinary strategies to optimize outcomes by proactive mitigation of known treatment-related side effects in caring for patients with GU malignancies.
• Assess recent practice-changing clinical trial findings concerning novel compounds or strategies to manage GU malignancies.
• Apply emerging clinical concepts to support the management of GU malignancies in consideration of evolving treatment paradigms in the field.

Additional details will be posted as soon as they are available.